Skip to content
    • About Us
      • About Us

        Partnering on drug discovery for over 25 years

      • Leadership Team Team Experienced leaders guiding scientific vision, operational excellence and collaborative partnerships.
      • Careers Careers Join scientists advancing innovation and making meaningful impact within discovery.
    • Drug Discovery
      • Drug Discovery

        Integrated discovery from target to candidate

      • Our Capabilities

        Delivered independently or as part of an integrated programme

        • Protein Sciences Protein Sciences Expert protein production to power your programme.
        • Hit ID Hit ID Platform End-to-end hit identification across our platforms.
        • Chemistry Chemistry Integrated chemistry to design and optimise compounds.
        • Structural Biology Structural Biology Structures to guide faster, smarter drug design.
        • Biophysics Biophysics Precise binding data to validate and rank your hits.
        • Informatics Informatics Data science to accelerate your discovery programme.
        • Cell Biology Cell Biology Cellular assays to confirm activity and engagement.
        • ADME / DMPK ADME/DMPK Early ADME profiling to shape your compound profile. 
        • In Vivo In Vivo In vivo pharmacology through our HitGen partnership.

        DEL Services

        • DEL DEL Screening billions of compounds in one experiment.
        • PAC-DEL PAC-FragmentDEL DEL screening for the most challenging targets.
        • Fragment-based Drug Discovery Fragment-Based Drug Discovery Fragment screening and evolution into quality leads.
    • Insights
      • Insights

        The science and results behind our programmes

      • Case Studies Case Studies Real project examples demonstrating our scientific approach and measurable impact.
      • Publications Publications Peer‑reviewed publications showcasing our scientific contributions and discovery expertise globally.
    • News & Events
      • News & Events

        Updates on our latest milestones and scientific contributions.

      • News News Updates on our latest milestones and scientific contributions.
      • Events Events Updates on our industry appearances and upcoming opportunities to meet our team.
    Partner with us

News & Events

Latest News

Updates on our latest milestones, scientific contributions and industry appearances.

Vernalis joins the LIGAND-AI Consortium 20/02/26 Read more C4X Discovery and Vernalis announce a drug discovery collaboration in inflammatory disease 08/04/24 Read more Hox Therapeutics and Vernalis announce a drug discovery collaboration in oncology 15/02/24 Read more Venture forces invest millions in new type of treatment for particularly aggressive form of cancer 18/10/23 Read more Pierre Fabre Laboratories and Vernalis announce a drug discovery collaboration in oncology 25/09/23 Read more

Vernalis is a member of the HitGen group of companies

© 2026 Vernalis (R&D) Limited.

    • LinkedIn
  • Privacy Policy
  • Terms & Conditions

Website design & development by Sciad Communications Ltd

Search Vernalis.com

Quick Links

  • Hit ID Hit ID Platform
  • Structural Biology Structural Biology
  • DEL DEL
  • Fragment-based Drug Discovery Fragment-Based Drug Discovery
  • Case Studies Case Studies
  • Publications Publications
  • News News
  • Events Events
  • Leadership Team Team
  • Careers Careers